Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Gains 8%; BSE HEALTHCARE Index Down 0.3%
Mon, 9 Sep 12:18

Jubilant Pharmova Gains 8%; BSE HEALTHCARE Index Down 0.3%Image source: Sefa Ozel/www.istockphoto.com

Jubilant Pharmova share price has zoomed 8% and is presently trading at Rs 1,028.7.

Meanwhile, the BSE HEALTHCARE index is at 43,320.4 (down 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 6.9%) and ALEMBIC PHARMA (up 4.3%).

GRANULES INDIA (down 3.4%) and POLY MEDICURE (down 2.1%) are among the top losers today.

Over the last one year, Jubilant Pharmova has moved up from Rs 462.9 to Rs 1,028.7, registering a gain of Rs 565.8 (up 122.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,163.1 to 43,320.4, registering a gain of 53.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 133.1%), Jubilant Pharmova (up 122.2%) and Glenmark Pharma (up 114.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,234.3 (up 0.1%).

The top gainers among the BSE Sensex today are Hindustan Unilever (up 1.8%) and ITC (up 1.0%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,852.0 . ONGC and Hindalco are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,780.3 to 81,234.3, registering a gain of 15,454.1 points (up 23.5%).

Jubilant Pharmova Financial Update...

Jubilant Pharmova net profit grew 6410.8% YoY to Rs 4,818 million for the quarter ended June 2024, compared to a profit of Rs 74 million a year ago. Net sales rose 9.1% to Rs 17,317 million during the period as against Rs 15,869 million in April-June 2023.

For the year ended March 2024, Jubilant Pharmova reported 212.0% increase in net profit to Rs 727 million compared to net loss of Rs 649 million during FY23. Revenue of the company grew 6.7% to Rs 67,029 million during FY24.

The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 31.3.


Equitymaster requests your view! Post a comment on "Jubilant Pharmova Gains 8%; BSE HEALTHCARE Index Down 0.3%". Click here!